Evidence map›Paper›PMID 35237297›Full record

ArticleFrontiers in genetics2021

Mitochondrial-Associated Protein LRPPRC is Related With Poor Prognosis Potentially and Exerts as an Oncogene

Li Wang, Jun Luo, Yuchen Li, Yanrong Lu, Yi Zhang, Bole Tian, Ziyi Zhao, Qiong-Ying Hu

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Li WangDepartment of Pancreatic Surgery, West China Hospital of Sichuan University, Chengdu, China.
Jun LuoSchool of Medicine, Chengdu Women's and Children's Central Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Yuchen LiCollege of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yanrong LuKey Laboratory of Transplant Engineering and Immunology, West China Hospital of Sichuan University, Chengdu, China.
Yi ZhangDepartment of Pancreatic Surgery, West China Hospital of Sichuan University, Chengdu, China.
Bole TianDepartment of Pancreatic Surgery, West China Hospital of Sichuan University, Chengdu, China.
Ziyi ZhaoDepartment of Laboratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Qiong-Ying HuDepartment of Laboratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Sichuan University · CNWest China Hospital of Sichuan University · CNChengdu University of Traditional Chinese Medicine · CNUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autophagy/mitophagychemoresistanceLRPPRCmitochondrial homeostasispancreatic cancerreactive oxygen species (ROS)

Identifiers

PMID35237297
PMCPMC8885106
OpenAlexW4226198976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.